11,685 Shares in Agilent Technologies, Inc. $A Acquired by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,685 shares of the medical research company's stock, valued at approximately $1,552,000.

Several other institutional investors also recently bought and sold shares of A. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock valued at $82,712,000 after acquiring an additional 24,687 shares in the last quarter. Dudley & Shanley Inc. boosted its stake in Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock worth $9,232,000 after purchasing an additional 14,300 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock worth $4,615,000 after purchasing an additional 9,615 shares during the last quarter. Capricorn Fund Managers Ltd purchased a new stake in Agilent Technologies during the 1st quarter worth approximately $8,161,000. Finally, BIP Wealth LLC purchased a new stake in Agilent Technologies during the 2nd quarter worth approximately $834,000.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on A shares. TD Cowen raised their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a report on Thursday, May 28th. HSBC dropped their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Royal Bank Of Canada started coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 target price on the stock. Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 26th. Finally, Wolfe Research restated a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $160.24.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $159.25 on Friday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The company's 50 day moving average is $137.57 and its 200 day moving average is $126.23. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a market cap of $44.98 billion, a PE ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same period in the previous year, the business posted $1.31 EPS. The business's quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source